v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 33,397 $ 41,375 $ 67,502 $ 81,937
General and administrative 11,042 13,117 28,447 26,401
Total operating expenses 44,439 54,492 95,949 108,338
Loss from operations (43,285) (53,377) (93,939) (105,769)
Other income:        
Interest income 788 743 1,809 1,925
Accretion (amortization) of investments 333 530 793 869
Change in fair value of short-term investment — related party 0 (505) 0 (1,561)
Other income, net 55 18 106 55
Total other income, net 1,176 786 2,708 1,288
Net loss attributable to common stockholders, basic (42,109) (52,591) (91,231) (104,481)
Net loss attributable to common stockholders, diluted $ (42,109) $ (52,591) $ (91,231) $ (104,481)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.24) $ (0.41) $ (0.51) $ (0.81)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.24) $ (0.41) $ (0.51) $ (0.81)
Weighted-average common shares outstanding, basic (in shares) 177,224,892 129,185,918 177,160,914 128,439,349
Weighted-average common shares outstanding, diluted (in shares) 177,224,892 129,185,918 177,160,914 128,439,349
Comprehensive loss:        
Net loss $ (42,109) $ (52,591) $ (91,231) $ (104,481)
Change in unrealized (loss) income on investments, net of tax (8) 5 (91) (11)
Comprehensive loss (42,117) (52,586) (91,322) (104,492)
Related Party        
Revenue:        
Collaboration revenue — related party $ 1,154 $ 1,115 $ 2,010 $ 2,569